Advanced Micro Devices Inc. (AMD) stock tumbled more than 3% in pre-market trading on Wednesday after HSBC analysts double ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Among Nvidia, Apple, Microsoft, Amazon, Alphabet, Meta Platforms, and Tesla, there's a phenomenal bargain hiding in plain ...

Dell Technologies (NYSE: DELL) builds on decades of PC innovation with a new, simplified portfolio featuring on-device AI for ...

Many tech stocks soared over the past year as expectations for lower interest rates and milder macroeconomic headwinds ...

iShares U.S. Technology ETF IYW -2.29% + Free Alerts has $20.5 billion funds under management and charges an expense ratio of ...

CES 2025 is undoubtedly the biggest tech event of the year and we're expecting an avalanche of news and announcements each ...

Intel has been steadily losing share in the PC CPU market to Advanced Micro Devices over much of the past decade. In the ...

Advanced Micro Devices AMD at a press conference prior to CES 2025 unveiled new cutting-edge AI PC processors for consumers ...